The high CBO score is delaying the bipartisan bill — It may face budgetary constraints and hinder its passage.
Bipartisan interest exists but has not moved the bill forward since June 2025 — Cooperation might be needed to adjust the estimate for re-scoring.
Fique de olho:
Further negotiations with the CBO could potentially lower the score, advancing the legislation.
A bipartisan bill aimed at combating hepatitis C is stalled in the Senate due to a high score from the Congressional Budget Office, the bill’s lead sponsor Bill Cassidy, R-La., said on Thursday. The bill, co-sponsored by Sen Chris Van Hollen, D-Md.
